B-Secur
PrivateLast Round
Series B
Nov 5, 2021
Total Funding Raised
$26.22M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
B-Secur operates in Healthcare & Life Sciences and is based in Belfast. Its latest recorded funding round was a Series B round in November 2021.
B-Secur is a health technology company that develops FDA-cleared, medical-grade ECG biosensing algorithms for integration into consumer wearables and medical devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Consumer Electronics, Identity & Access
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
B-Secur Comparables
Compare B-Secur with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardioID Technologies | 76% | |
| LifeQ | 76% | |
| Philips | 75% |
For institutional investors. Book with your work email.
B-Secur Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2021 | ||||
| Convertible Debt | Sep 15, 2020 | ||||
| Convertible Debt | May 1, 2020 | ||||
| Series A Extension | Mar 5, 2019 | ||||
| Seed | Jul 25, 2017 | ||||
Grant | Sep 2, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
B-Secur Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Accelerated Digital Ventures | Convertible Debt, Series A Extension, Seed |
| Kernel Capital | Convertible Debt, Series A Extension, Series B, Seed |
| British Business Bank | Convertible Debt |
| Invest Northern Ireland | Grant |
| First Capital Ventures | Series B |
| Clarendon Fund Managers | Convertible Debt, Series B |
| Wharton Asset Management Company | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 72% MoM, reaching 6.1K.
- Nov 5, 2025
Partnered with Orlando Health on a pilot program for biometric insights.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 7, 2026
B-Secur launches its ECG Test System (ETS), a reference-based system that gives wearable device manufacturers an objective, standardised measure of ECG signal quality throughout product development, on Oct 7th '26.
For institutional investors. Book with your work email.
B-Secur Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about B-Secur's valuation, stock price, and market status.
Is B-Secur a public or private company?
B-Secur is a private company.
What is the current stock price of B-Secur?
B-Secur is a private company, so its shares have no public market price. Caplight tracks B-Secur's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is B-Secur worth (valuation)?
Valuation information for B-Secur is not publicly available.
Can I buy B-Secur stock?
B-Secur shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was B-Secur's last funding round?
B-Secur's most recent funding round was Series B on November 5, 2021.
Who are the main investors in B-Secur?
Key investors in B-Secur include Accelerated Digital Ventures, Kernel Capital, First Capital Ventures.
Will B-Secur IPO soon?
No public IPO plans have been announced for B-Secur.
How can I track B-Secur secondary market activity?
Caplight tracks bids, offers, and trades in B-Secur's shares on secondary markets.